Virtual Run
Register Here
2026 Spring Newsletter
Read Now
AL Amyloidosis
Read More
Amyloidosis Awareness Items
Shop Here
Hereditary Amyloidosis
Get the Facts Here
The Amyloidosis Channel
View Here
Patient Education Activity
Read More HereWhat is Amyloidosis?
Most amyloidosis diseases have different treatments; therefore, the correct diagnosis is extremely important.
Featured Patient Story
My hTTR-PN Journey
Tisha Downing
Latest Headlines
Immix Biopharma Announces 95% Complete Response Rate in Interim Update From relapsed/refractory AL Amyloidosis Clinical Trial NEXICART-2
July 23, 2026
– Of first 20 patients, all four MRD-negative patients have converted to complete response (CR) –
– CR rate now 95% (19 of 20 patients) –
– All CRs reached within 1 year of follow-up post-dosing –
...Calendar & Upcoming Events
Cardiac Testing in Amyloidosis
Webinar Session: Wednesday, August 26th at 6 PM (ET) Zoom Meeting
(These sessions will not be recorded due to patient involvement and HIPAA laws)
To Register HERE
Cardiac Testing in Amyloidosis
Learn how cardiac testing can help detect and monitor heart involvement in amyloidosis. We will explain common tests, what to expect, and how results may guide care, with time for patient and caregiver questions.
Hasan Siddiqi MD, MSCR, FACC is an advanced heart failure cardiologist and directs its cardiac amyloidosis program. He manages amyloidosis, heart failure, VAD, and transplant patients in the world’s largest heart transplant center, leads research and trials, and trained at Harvard, Michigan, Penn, and Brigham.
Speaker: Hasan Siddiqi MD, MSCR, FACC
How I Evaluate and Treat Peripheral Neuropathy in ATTR & AL Amyloidosis
Webinar Session: Wednesday, August 19th at 6 PM (ET) Zoom Meeting
(These sessions will not be recorded due to patient involvement and HIPAA laws)
To Register HERE
How I Evaluate and Treat Peripheral Neuropathy in ATTR & AL Amyloidosis
Learn how peripheral neuropathy is evaluated and treated in patients with amyloidosis, including TTR and AL types. This session reviews diagnostic approaches, symptom management, rehabilitation strategies, treatment options, and disease-modifying therapies that may help patients and care partners understand next steps, care planning, and support.
Amanda C. Peltier, MD, MS, is Professor of Neurology and Medicine and Chief of the Neuromuscular Division at Vanderbilt University Medical Center. Her work focuses on peripheral neuropathies, including amyloidosis-related peripheral and autonomic neuropathy. She is active in ATTR neuropathy guideline work and has contributed to identifying clinical trial endpoints for neuropathy.
Speaker: Amanda C. Peltier, MD, MS
Misfolded Proteins: How Amyloidosis Impacts Kidney Function
Webinar Session: Wednesday, August 12th at 6 PM (ET) Zoom Meeting
(These sessions will not be recorded due to patient involvement and HIPAA laws)
To Register HERE
Misfolded Proteins: How Amyloidosis Impacts Kidney Function
Learn how AL amyloidosis damages the kidneys, why early recognition is critical, and how today’s treatments can slow disease progression and preserve kidney function. We’ll also highlight the growth of Vanderbilt’s Amyloidosis Program (VAMP) and its impact on improving care across the region.
Anthony J. Langone, MD MS is a nephrologist and transplant specialist focused on kidney and pancreas transplantation, amyloidosis, and multiple myeloma. He supports patients with renal involvement in amyloidosis and brings research experience in medication side effects, biomarkers, transplant care, and kidney protection strategies.
Speaker: Anthony J. Langone, MD MS
Amyloidosis Videos
Featured Product
Zebra T Shirt
